Skip to main content

Sparrow Pharmaceuticals

Portland, United States

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

$95.0M raised
Sep 2025
Series B

Top Investors

RA Capital ManagementOrbiMedForbion Capital PartnersU.S. Venture PartnersRiverVest

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Sparrow Pharmaceuticals

How much funding has Sparrow Pharmaceuticals raised?
Sparrow Pharmaceuticals has raised $95.0M in total funding. The most recent round was Series B. The last funding was announced in September 2025.
Who are Sparrow Pharmaceuticals's investors?
Sparrow Pharmaceuticals's investors include RA Capital Management, OrbiMed, Forbion Capital Partners, U.S. Venture Partners, RiverVest.
Where is Sparrow Pharmaceuticals headquartered?
Sparrow Pharmaceuticals is headquartered in Portland, United States.
What does Sparrow Pharmaceuticals do?
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.
What stage is Sparrow Pharmaceuticals at?
Sparrow Pharmaceuticals is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Sparrow Pharmaceuticals — Funding & Investors." VCBacked, September 24, 2025, https://www.vcbacked.co/company/sparrow-pharmaceuticals. Accessed June 4, 2026.
APA
VCBacked. (2025). Sparrow Pharmaceuticals — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/sparrow-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Sparrow Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/sparrow-pharmaceuticals |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .